Acyclovir
- Product NDC
- 42254-133
- 11-digit product format
- 422540133
- Labeler code
- 42254
- Product ID
- 42254-133_ec3d8135-2892-4186-ac31-c7deadd0b975
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- ANDA075382
- Marketing category
- ANDA
- Marketing start
- 2009-10-22
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42254-133-15 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
| 42254-133-20 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
| 42254-133-21 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
| 42254-133-25 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
| 42254-133-30 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
| 42254-133-60 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
| 42254-133-90 | 2019-09-24 | C162847 | 48780-1 | 9350213a-3dac-c013-e053-90daa90a1393 | Acyclovir |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42254-133-15 | Acyclovir | 15 in 1 BOTTLE | TABLET | 15 | 3 | |
| 42254-133-20 | Acyclovir | 20 in 1 BOTTLE | TABLET | 20 | 3 | |
| 42254-133-21 | Acyclovir | 21 in 1 BOTTLE | TABLET | 21 | 3 | |
| 42254-133-25 | Acyclovir | 25 in 1 BOTTLE | TABLET | 25 | 3 | |
| 42254-133-30 | Acyclovir | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 42254-133-60 | Acyclovir | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 42254-133-90 | Acyclovir | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42254-133-15 | EA - Each | 42254-133 | 0426631c-d5ad-4494-bc3f-14641d1471fb | 1 | 2013-03-03 |
| 42254-133-20 | EA - Each | 42254-133 | 622999df-2750-4d88-ad07-718336b39d18 | 1 | 2013-02-19 |
| 42254-133-21 | EA - Each | 42254-133 | 4e163c60-40d7-4369-820f-b8629b3fcb7e | 1 | 2013-02-19 |
| 42254-133-25 | EA - Each | 42254-133 | e2f36ba5-b2e6-4580-b17a-34bf2ffcb91f | 1 | 2013-02-19 |
| 42254-133-30 | EA - Each | 42254-133 | 03a702f5-16fd-4ec2-ba7a-f26d9c4f3d39 | 1 | 2012-07-24 |
| 42254-133-60 | EA - Each | 42254-133 | 89c1d401-fc17-44ad-8bd9-5f6afdb51d4d | 1 | 2013-03-03 |
| 42254-133-90 | EA - Each | 42254-133 | 3bd1624a-3c58-4577-b85f-7fd424fb13f3 | 1 | 2013-02-19 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Acyclovir | ACTIVE INGREDIENT | X4HES1O11F | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 | |
| acyclovir | ACTIVE MOIETY | X4HES1O11F | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ACYCLOVIR TABLET [REBEL DISTRIBUTORS CORP] | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197311 | acyclovir 400 MG Oral Tablet | PSN | bf1e7864-07c5-4c2c-a075-fad00612ee2a | 3 |
| 197313 | acyclovir 800 MG Oral Tablet | PSN | bf1e7864-07c5-4c2c-a075-fad00612ee2a | 3 |
| 197311 | acyclovir 400 MG Oral Tablet | SCD | bf1e7864-07c5-4c2c-a075-fad00612ee2a | 3 |
| 197313 | acyclovir 800 MG Oral Tablet | SCD | bf1e7864-07c5-4c2c-a075-fad00612ee2a | 3 |
| 197311 | acycycloguanosine 400 MG Oral Tablet | SY | bf1e7864-07c5-4c2c-a075-fad00612ee2a | 3 |
| 197313 | acycycloguanosine 800 MG Oral Tablet | SY | bf1e7864-07c5-4c2c-a075-fad00612ee2a | 3 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 42254-133-15 | 42254013315 | 15 in 1 BOTTLE | Historical |
| 42254-133-20 | 42254013320 | 20 in 1 BOTTLE | Historical |
| 42254-133-21 | 42254013321 | 21 in 1 BOTTLE | Historical |
| 42254-133-25 | 42254013325 | 25 in 1 BOTTLE | Historical |
| 42254-133-30 | 42254013330 | 30 in 1 BOTTLE | Historical |
| 42254-133-60 | 42254013360 | 60 in 1 BOTTLE | Historical |
| 42254-133-90 | 42254013390 | 90 in 1 BOTTLE | Historical |